IMRA - Imara Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 2023-08-07    (Delayed quote data   2025-09-12)
Last
 37.98		 Change
 ⇑ +1.19   (+3.23%)		 Volume
  7,276
Open
 37.27		 High
 38.25		 Low
 36.99
8EMA (Daily)
 36.81		 40EMA (Daily)
 39.59		 50EMA (Daily)
 40.30		 STO (Daily)
 59.098		 MACD Hist (Daily)
 0.807
8EMA (Weekly)
 39.081		 40EMA (Weekly)
 32.41		 50EMA (Weekly)
 29.29		 STO (Weekly)
 9.127		 MACD Hist (Weekly)
 -4.893
Company Profile
Imara Inc is a clinical-stage biopharmaceutical company engaged in developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of haemoglobin.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com